136 related articles for article (PubMed ID: 33842612)
1. Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis.
Chen E; Wu J; Liu Z; Yang S; Wu J; Ouyang P; Xie F
Ann Transl Med; 2021 Mar; 9(5):391. PubMed ID: 33842612
[TBL] [Abstract][Full Text] [Related]
2. Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis.
Wang JQ; Deng RX; Liu H; Luo Y; Lu MM; Yang ZC
Front Oncol; 2022; 12():754967. PubMed ID: 35847870
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Therapy and Prognosticators of Survival in Head and Neck Mucosal Melanoma.
Abiri A; Yasaka TM; Lehrich BM; Goshtasbi K; Papagiannopoulos P; Tajudeen BA; St John MA; Harris JP; Kuan EC
Laryngoscope; 2022 Mar; 132(3):584-592. PubMed ID: 34355791
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease.
Ohshima S; Ueki Y; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Okabe R; Matsuyama H; Togashi T; Takatsuka S; Takenouchi T; Horii A
Front Surg; 2022; 9():1032626. PubMed ID: 37082097
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis.
Li W; Yu Y; Wang H; Yan A; Jiang X
BMC Cancer; 2015 Oct; 15():758. PubMed ID: 26490539
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma.
Wushou A; Hou J; Zhao YJ; Miao XC
J Craniomaxillofac Surg; 2015 May; 43(4):553-8. PubMed ID: 25797388
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival in head and neck mucosal melanoma.
Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of prognostic factors for survival in patients with head and neck mucosal melanoma].
Wu X; Feng Y; Zeng C; Wang M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jul; 34(7):647-651. PubMed ID: 32791644
[No Abstract] [Full Text] [Related]
10. Primary head and neck mucosal melanoma: Predictors of survival and a case series on sentinel node biopsy.
Prinzen T; Klein M; Hallermann C; Wermker K
J Craniomaxillofac Surg; 2019 Sep; 47(9):1370-1377. PubMed ID: 31331857
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
[TBL] [Abstract][Full Text] [Related]
12. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Facility Type and Volume on Outcomes in Head and Neck Mucosal Melanoma.
Roman KM; Torabi SJ; Bitner BF; Goshtasbi K; Haidar YM; Tjoa T; Kuan EC
Otolaryngol Head Neck Surg; 2023 May; 168(5):1079-1088. PubMed ID: 36939581
[TBL] [Abstract][Full Text] [Related]
14. Determining the epidemiologic, outcome, and prognostic factors of oral malignant melanoma by using the Surveillance, Epidemiology, and End Results database.
Lee RJ; Lee SA; Lin T; Lee KK; Christensen RE
J Am Dent Assoc; 2017 May; 148(5):288-297. PubMed ID: 28325493
[TBL] [Abstract][Full Text] [Related]
15. Risk-based stratification in head and neck mucosal melanoma.
Moya-Plana A; Mangin D; Dercle L; Taouachi R; Casiraghi O; Ammari S; Nguyen F; Temam S; Robert C; Gorphe P
Oral Oncol; 2019 Oct; 97():44-49. PubMed ID: 31421470
[TBL] [Abstract][Full Text] [Related]
16. Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.
Arshi A; Tajudeen BA; St John M
Oral Oncol; 2015 Dec; 51(12):1088-94. PubMed ID: 26442813
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
Lee KC; Chuang SK; Philipone EM; Peters SM
Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
[TBL] [Abstract][Full Text] [Related]
18. Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital.
Chan RC; Chan JY; Wei WI
Laryngoscope; 2012 Dec; 122(12):2749-53. PubMed ID: 23161468
[TBL] [Abstract][Full Text] [Related]
19. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
20. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
